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The rapid diagnosis ofviral infections is an important tool in the management ofpatients with
infectious diseases. Solid-phase enzyme immunoassays have proved to be useful tools for the
direct detection of the antigens of some viruses directly in clinical specimens. Such assays have
been particularly useful in the diagnosis ofviral infections in the gastrointestinal and respiratory
tracts. However, standard solid-phase enzyme immunoassays often do not display sufficient
sensitivity for the diagnosis of all cases ofviral infections. Techniques which might be utilized to
increase the sensitivity of solid-phase immunoassays include the use of monoclonal antibodies to
maximize the efficiency of the antigen-antibody interactions and the use of high-turnover
enzymes to increase the amountofsignal generated by theensuing enzyme-substrate reactions. In
addition, techniques making useofnucleic acid hybridization havea great dealofpotential for the
accurate detection ofviral nucleic acids in human body fluids. The successful application ofthese
techniques to the diagnosis ofviral infections could lead to a marked improvement in the care of
patients with suspected infectious diseases as well as to a decrease in the transmission of viral
infections to high-risk individuals.
During the past years, great strides have been made in the development ofpractical
assay systems for the rapid diagnosis ofviral infections. Many ofthese advances have
resulted from the widespread application of solid-phase enzyme immunoassay tech-
niques to thedirect detection ofviral antigens in clinical samples [1-5] (Figs. 1, 2) and
in the development of assay systems suitable for the detection of a wide range ofviral
infections ofthe respiratory, gastrointestinal, and genital tract [6-13]. However, while
there has been significant progress in thedevelopment ofsolid-phase immunoassays for
viral immunodiagnostics, there are limitations to the sensitivity and practicality of
immunoassay systems utilizing traditional reaction formats [1,14-16]. These limita-
tions are based on constraints inherent in the kinetics ofantigen-antibody interactions.
Such constraints are particularly problematic when the antibody is linked to large
enzymatic molecules and the diffusion and antigen-binding capabilities of the immu-
noglobulin are further limited [21]. These limitations can preclude the effective use of
traditional solid-phase immunoassay techniques for the diagnosis ofviral infections in
situations in which low concentrations ofantigen are present. Such situations are likely
to occur very early in the course of infection, when little viral antigen has been
produced, or late in the course of infection, when much of the viral antigen is
complexed with endogenous antibody and is thus inaccessable to labeled antibodies
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[17-19]. Also, viral antigens which are sequestered in intracellular sites have little
chance of reacting with labeled immunoglobulin macromolecules [20,21]. In addition
to limitations of sensitivity, traditional solid-phase immunoassays require multiple
incubation and washing steps to attain adequate degrees of sensitivity. The need for
these reaction steps limits the use oftraditional immunoassays to laboratories capable
of performing the assay procedures and renders the assays difficult to perform in
outpatient settings such as doctors' offices and clinics.
Recently, however, there have been a number of advances in the area of diagnostic
technology which can be applied to the development of practical assays for the rapid
diagnosis of viral infections. Such advances include the development of monoclonal
antibodies [22,23], improved methods for the linkage of low molecular weight ligands
to immunoglobulin molecules [24,25], sensitive methods for the measurement of
specific anti-viral antibodies and endogenous immune complexes which develop early
in the course of infection [26,27], and the application of nucleic acid hybridization
techniques for microbial detection [28,29]. These advances might provide for means by
which immunoassay systems can attain increased levels ofsensitivity and specificity.
In the case of monoclonal antibodies, it is well recognized that the production of
monoclonal antibodies with the desired specificities offers a number of potential
advantages for the detection of defined viral antigens. These advantages include the
fact that hybridoma technology provides for an unlimited supply of a consistent
reagent which can unequivocally distinguish viral from host antigens [22,23]. In
addition, the fact that each molecule of monoclonal antibody is directed at the target
viral antigen can result in an effective increase in the active antibody concentration and
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FIG. 2. Double determinant enzyme immunoassay.
a subsequent increase in antigen-antibody interaction [30,31]. We have found that,
while some monoclonal antibodies can be used efficiently in such formats, many
monoclonal antibodies do not have sufficient affinity to be useful in such systems
[32,33]. The use of low-affinity antibodies is particularly problematic when the
monoclonal antibodies are utilized in solid-phase formats which require multiple
incubations, since the dissociation oflow-affinity antibodies can occur at each reaction
step. Thus many anti-viral monoclonal antibodies which arecurrently available are not
suitable for use in traditional solid-phase immunoassays. For this reason there is a need
for thedevelopment ofassay formats which are not limited in termsofimmunoglobulin
concentrations and thus can counterbalance lower affinity by the application of the
antibodies at higher concentrations. In addition, methods of monoclonal antibody
production which would ensure the consistent generation of high-affinity antibodies
would represent a significant advance in the application of monoclonal antibodies to
the field ofmicrobial diagnostics.
The use of enzymatic molecules as immunoglobulin labels offers a number of
advantages in terms ofsensitivity, safety, and convenience. However, all enzymes are
relatively large molecules (>45,000 daltons). The enzyme-immunoglobulin conjuga-
tion procedure thus results in a hybrid molecule which is substantially larger than
native immunoglobulin and thus exhibits suboptimal diffusion and binding character-
istics [35,36]. For this reason, techniques which utilize the labeling ofimmunoglobulin
with low molecular weight labels in place of macromolecular enzymes result in
immunoglobulin conjugates with improved performance characteristics in immunoas-
saysystems for thedetection ofviral antigens [37]. Such systems areformulated bythe
labeling of immunoglobulin with a low molecular weight ligand and the subsequent
completion of the reaction by the binding of the ligand with an enzymatic molecule
which has been modified to specifically recognize the ligand. Since the enzyme-ligand
reaction is performed after the antigen-antibody reaction is completed, it does not
adversely affect the ability of antibody to bind to antigen in the clinical specimen.
While numerous low molecular weight ligands can be utilized in this format, we have
found that the use ofthe avidin-biotin system offers a number ofpractical advantages
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[8,25,37,38]. These advantages include the high affinity ofbiotin for anti-ligands such
as avidin, and the widespread availability ofbiotin and avidin reagents suitable for use
in immunoassay systems. The linkage ofbiotin to the immunoglobulin can most easily
be accomplished by the epsilon amino groups oflysine residues ofthe immunoglobulin
by simple reaction with the n-hydroxy-succinimide ester of biotin. In some cases,
however, the labeling can most efficiently be accomplished by linkage through
carboxyl [20,39] as sulfhydrl [40] moieties on the immunoglobulin molecule. We have
found, for example, that some monoclonal antibodies which cannot be efficiently
labeled by reaction with amino groups can be labeled by reaction through these
reactive sites. We have found that the avidin-biotin reaction system can bequantitated
most efficiently by the binding ofthe biotinillated antibody with avidin complexed with
biotin modified enzyme. The use of an avidin-biotin complex in this way allows for the
maximum retention of native enzymatic activity with a resulting optimization of
substrate generation and assay sensitivity. In addition, the simple nature of biotin
labeling allows for the labeling of a large number of different immunoglobulin
molecules in a reproducible fashion. This fact permits the evaluation ofa large number
of different antibodies directed at the target antigen. Such evaluation is particularly
useful in the development ofnew assay systems when a large number ofpolyclonal and
monoclonal antibodies must be evaluated in order todeterminewhich isoptimal for use
in the immunoassay system. The avidin-biotin system is thus also useful in the
development and optimization of novel assay systems for the detection of new
antigen.
An additional advance in the area of viral diagnosis has been an increased
knowledge ofthe early immune response to viral infections in humans. We have found,
for example, that viral infections are often accompanied by the presence of viral-
specific immunecomplexes in the infected body site. Thesecomplexes areoften present
in antigen excess and thus contain antigenic sites which are accessible to labeled
antibodies. This fact allows for the detection of the specific immune complexes by
means ofsolid-phase immunoassay techniques. Preliminary studies have indicated that
the detection of immune complexes can be accomplished in situations in which free
antigen cannot be detected. The ability to detect such viral-specific immune complexes
thus could markedly expand the applicability of viral diagnostic assays for the
diagnosis ofsuch infection.
One problem inherent in all immunoassays is the limitation imposed by the kinetics
ofantigen-antibody reactions. For this reason it would be desirable to utilize detection
systems which do not rely on antigen-antibody interactions. One such system which
offers a great deal ofpotential for viral diagnosis is that of nucleic acid hybridization.
Unlike immunoassays, nucleic acid hybridization systems are not limited by the
constraints ofantigen-antibody reactions [28,29]. Rather, the parameters ofreactivity
are determined by the association kinetics of nucleotide base pairing. Since each
nucleotide can participate in a hydrogen-binding reaction, the kinetics of nucleic acid
reassociation is extremely favorable. An additional advantage ofnucleic acid hybridi-
zations is that recombinant DNA and other cloning techniques can be utilized to
produce large quantities of nucleotide probes with defined degrees of specificity. This
fact offers a significant advantage in terms ofreagent production and standardization.
For these reasons nucleic acid hybridization has been applied to the detection of a
number of viral antigens in clinical samples. However, one limitation of nucleic acid
detection techniques is that they have relied largely on the use ofradioactive isotopes to
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achieve nucleotide detection. The use of isotopes is particularly problematic since the
isotope which has been most widely used for this purpose, p32, is particularly hazardous
and unstable. While non-isotopic nucleic acid labels have been proposed [41,42],
available labeling systems involve the useofextensively modified nucleotides which are
expensive and difficult to obtain. However, the development of chemical methods for
modifying nucleic acids would allow for the use of non-isotopic probes without these
limitations. The practical adaptation of nucleic acid hybridization systems for viral
diagnosis might represent a marked advance in the area of practical, sensitive viral
diagnostics available to the clinical laboratory.
From the above discussion it is clear that there are a number of ways in which
currently available microbial assay systems can be improved in order to provide for
accurate, practical diagnoses of viral infections under a wide range of clinical and
laboratory conditions. While there are numerous ways in which the assay systems can
be modified, it is likely that significant advances in microbial diagnosis will derive from
developments in the following areas:
1. Improved antigen-antibody interaction formats
2. Increased magnification of the antigen-antibody interaction by means of
sensitive indicator systems
3. The optimization ofsimplified, rapid assay formats
4. Improved assays for the detection ofviral-specific immune complexes
5. The adaptation of nucleic acid hybridization techniques to formats that are
practical for microbiology laboratories
Our experience with assay systems suggests that it is unlikely that a single assay
system will find universal acceptance for the detection ofviral pathogens in all possible
clinical and laboratory conditions. For example, clinical laboratories at teaching
institutions might make good useofassay systems which are sensitive and applicable to
a wide range of microorganisms but which might be tedious to perform and which
might require some expertise or specialized equipment. On the other hand, medical
practitioners will be able to best utilize assay systems which are rapid and simple to
perform but which are targeted to microorganisms for which high degrees ofsensitivity
are not required. Thedevelopment ofa rangeofassay systems is the most effective way
ofinsuring the development ofassay systems which can be applied to the diagnosis ofa
wide range ofviral infections that occur in patients receiving medical care in teaching
hospitals, community hospitals, outpatient clinics, doctors' offices, and field stations in
the United States and other areas ofthe world.
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